Hastings Tessa J, Ha David, Fox Brent I, Qian Jingjing, Lakin Joni, Westrick Salisa C
J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1270-1279.e2. doi: 10.1016/j.japh.2022.02.010. Epub 2022 Feb 19.
Only 60% of adults nationwide and just 36.8% of adults in Alabama have immunization data recorded in an Immunization Information System (IIS). The objective of this study, which took place before the coronavirus disease 2019 (COVID-19) pandemic, was to evaluate the impact of an IIS training program on pharmacists' IIS enrollment, participation, awareness, knowledge, intention, and attitudes.
A randomized controlled trial was conducted in 2019 among Alabama pharmacists (N = 41) practicing in independently owned pharmacies and providing vaccination services but whose pharmacy was not enrolled in Alabama's IIS (Immunization Patient Registry with Integrated Technology [ImmPRINT]). Intervention pharmacists were offered a 2-hour IIS training program, including an online continuing pharmacy education article, demonstration videos, implementation guide, and informational flyer. Control pharmacies received the informational flyer only. Pharmacy-level outcomes, including enrollment and participation, were obtained from ImmPRINT administrative records. Pharmacist-level outcomes, including awareness, knowledge, intention, and attitudes, were self-reported using baseline, 1-month, and 3-month surveys. Two-way mixed analysis of variance, chi-square, and independent t tests were used to analyze differences in outcomes between and within groups.
Enrollment in ImmPRINT was significantly greater among intervention pharmacists' pharmacies (P = 0.035). In particular, 59.1% of intervention pharmacies compared with 26.3% of control pharmacies were enrolled in ImmPRINT at 3 months. No statistically significant differences were found between groups in terms of participation in ImmPRINT. Intervention pharmacists' awareness of IIS was significantly greater than control pharmacists (P = 0.028) at 1 month (postintervention). Furthermore, the IIS training program significantly improved intervention pharmacists' knowledge (P = 0.030) and attitudes (P = 0.016) toward IIS over 3 months compared with the control group.
This pharmacist-centered training program focused on practical strategies to integrate IIS into pharmacy workflow. Results show that pharmacists' enrollment, awareness, knowledge, and attitudes significantly improved as a result of this training. As pharmacists become more involved in immunization efforts, particularly in response to COVID-19, awareness of and participation in responsible immunization documentation are critical.
在全国范围内,只有60%的成年人以及阿拉巴马州仅36.8%的成年人在免疫信息系统(IIS)中有免疫接种数据记录。这项在2019年冠状病毒病(COVID-19)大流行之前进行的研究的目的是评估IIS培训计划对药剂师IIS注册、参与度、意识、知识、意愿和态度的影响。
2019年对在独立经营药店执业并提供疫苗接种服务但药店未加入阿拉巴马州IIS(综合技术免疫接种患者登记系统[ImmPRINT])的阿拉巴马州药剂师(N = 41)进行了一项随机对照试验。干预组药剂师参加了一个2小时的IIS培训计划,包括一篇在线继续药学教育文章、演示视频、实施指南和信息传单。对照组药店仅收到信息传单。药店层面的结果,包括注册和参与情况,从ImmPRINT管理记录中获取。药剂师层面的结果,包括意识、知识、意愿和态度,通过基线调查、1个月和3个月调查进行自我报告。使用双向混合方差分析、卡方检验和独立t检验来分析组间和组内结果的差异。
干预组药剂师所在药店的ImmPRINT注册率显著更高(P = 0.035)。特别是,3个月时,59.1%的干预组药店加入了ImmPRINT,而对照组药店这一比例为26.3%。在ImmPRINT参与度方面,两组之间未发现统计学上的显著差异。干预组药剂师在1个月(干预后)时对IIS的知晓率显著高于对照组药剂师(P = 0.028)。此外,与对照组相比,IIS培训计划在3个月内显著提高了干预组药剂师对IIS的知识(P = 0.030)和态度(P = 0.016)。
这个以药剂师为中心的培训计划侧重于将IIS整合到药房工作流程中的实用策略。结果表明,由于这项培训,药剂师的注册、意识、知识和态度有了显著改善。随着药剂师更多地参与免疫接种工作,特别是应对COVID-19,对负责任的免疫接种记录的认识和参与至关重要。